Despite recent biomedical breakthroughs and large genomic studies growing momentum, the Middle Eastern population, home to over 400 million people, is underrepresented in the …
A Elfatih, C Saad… - European Journal of …, 2024 - nature.com
Arabic populations are underrepresented in large genome projects; therefore, the frequency of clinically actionable variants among Arabs is largely unknown. Here, we investigated …
Mapping the Arab genome | Nature Genetics Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …
JF Borgio - Archives of Medical Science: AMS, 2021 - pmc.ncbi.nlm.nih.gov
More than 25 million DNA variations have been discovered as novel including major alleles from the Arab population. Exome studies on the Saudi genome discovered> 3000 novel …
Background Genome sequencing of large biobanks from under-represented ancestries provides a valuable resource for the interrogation of Mendelian disease burden at world …
O Demir, KA Saglam, M Yilmaz… - American Journal of …, 2024 - Wiley Online Library
Big data generated from exome sequencing (ES) and genome sequencing (GS) analyses can be used to detect actionable and high‐penetrance variants that are not directly …
STUDY QUESTION What is the load, distribution and added clinical value of secondary findings (SFs) identified in exome sequencing (ES) of patients with non-obstructive …
Y Kim, JM Kim, HW Cho, HY Park, MH Park - Human Genetics, 2023 - Springer
Exome and genome sequencing (ES/GS) in genetic medicine and research leads to discovering genomic secondary findings (SFs) unrelated to the purpose of the primary test …
A Skrahin, HA Cheema, M Hussain… - Life Science …, 2023 - life-science-alliance.org
Studies on genomic secondary findings (SFs) are diverse in participants' characteristics, sequencing methods, and versions of the ACMG SF list. Based on whole genome …